INFARMED Leadership Appointments: A New Era in ...

By João L. Carapinha

January 6, 2026

INFARMED Leadership Appointments: Renewed Expertise for Medicines Oversight The Portuguese Council of Ministers has issued
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Emblaveo MDR Infections: Evaluating a New Solution for Multidrug-Resistant Gr...
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...
UK Pharmaceutical Pricing Analysis: Impasse in VPAG Review Undermines Patient...
Achieving International Drug Price Parity: Trump’s Mandate
NICE HealthTech Methods Update
Navigating Challenges for Small Countries to Access Innovative Medicines
Urgent Call to Action for EU Clinical Trials Strategy